Home / Resource Library / PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH HIGH-RISK CLASSIC HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONT-LINE CHEMOTHERAPY: UPDATED RESULTS FROM KEYNOTE-667
PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH HIGH-RISK CLASSIC HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONT-LINE CHEMOTHERAPY: UPDATED RESULTS FROM KEYNOTE-667